The association between serum leptin levels and body mass index in polycystic ovarian syndrome patients
Keywords:
Body Mass Index, Hyperandrogenism, Obesity, Leptin, Polycystic ovary syndromeAbstract
Polycystic ovary syndrome (PCOS) is the most common endocrine abnormality in reproductive-age women, which is characterized by hyperandrogenism, anovulation, and polycystic ovaries. Some evidence suggested that leptin also causes PCOS due to its role in the female reproductive system. The physiological function of leptin controls the balance of energy and suppresses the center of appetite. Patients with PCOS may be underweight, normoweight, overweight, and obese, based on their body mass index (BMI), but obesity is a common clinical situation in PCOS. Obesity occurs when the level of leptin increases but cannot decrease appetite, resulting in leptin resistance. This study aimed to discover the connection between body mass index (BMI) and the level of leptin in patients with PCOS. Methods: A case-control sectional study included 100 women, divided between 50 women with polycystic ovary syndrome and 50 healthy women. They're aged from 18 to 40 years old. Samples were collected from Al-Batoul General Hospital and private clinics in Diyala Governorate during the period from December 2024 to end March 2025. Blood samples were collected under fasting conditions from every enrolled participant.
Downloads
References
Abass, R. A., & Hussein, A. A. (2025). The Relationship between Vitamins B12, B9, and D and Polycystic Ovarian Syndrome: A Review Article.
Abdulzahra, M. A., Abed, A. M., & Ali, A. M. (2023). Influence of Leptin and Adiponectin on Polycystic Ovary Syndrome in Obese Iraqi Patients. GENERAL MEDICINE, pp. 629-638
Allahbadia, G. N., & Merchant, R. (2011). Polycystic ovary syndrome and impact on health. Middle East Fertility Society Journal, 16(1), 19-37. https://doi.org/10.1016/j.mefs.2010.10.002
Al-Musawi, N. J., Qaysi, S. A., & Witwit, S. J. (2022). Effect of KISS1 gene variants (rs372790354 G> A and rs4889 G> A) on kisspeptin in patients with polycystic ovary syndrome in Iraq. J Adv Biotechnol Exp Ther, 5(3), 562-576.
Al-Musawi, T. J., Mengelizadeh, N., Al Rawi, O., & Balarak, D. (2022). Capacity and modeling of acid blue 113 dye adsorption onto chitosan magnetized by Fe2O3 nanoparticles. Journal of Polymers and the Environment, 30(1), 344-359.
Amitani, M., Asakawa, A., Amitani, H., & Inui, A. (2013). The role of leptin in the control of insulin-glucose axis. Frontiers in neuroscience, 7, 51.
Auda, S. A., Gatea, E. A., Radhi, Z. A., & Directorate, M. E. (2023). Evaluation of thyroid autoimmunity markers in polycystic ovarian syndrome in women. Biomedicine, 43(3), 893-896.
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., ... & Witchel, S. F. (2009). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and sterility, 91(2), 456-488.
Carmina, E., Bucchieri, S., Esposito, A., Del Puente, A., Mansueto, P., Orio, F., ... & Rini, G. (2007). Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. The Journal of Clinical Endocrinology & Metabolism, 92(7), 2500-2505.
Chakrabarti, J. (2013). Serum leptin level in women with polycystic ovary syndrome: correlation with adiposity, insulin, and circulating testosterone. Annals of medical and health sciences research, 3(2), 191.
Chen, C. I., Hsu, M. I., Lin, S. H., Chang, Y. C. I., Hsu, C. S., & Tzeng, C. R. (2015). Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome. Gynecological Endocrinology, 31(4), 264-268.
El Gharib, M. N., & Badawy, T. E. (2014). Correlation between insulin, leptin and polycystic ovary syndrome. Journal of Basic and Clinical Reproductive Sciences, 3(1), 49-53.
Frederiksen, B. N., Kroehl, M., Fingerlin, T. E., Wong, R., Steck, A. K., Rewers, M., & Norris, J. M. (2013). Association between vitamin D metabolism gene polymorphisms and risk of islet autoimmunity and progression to type 1 diabetes: the diabetes autoimmunity study in the young (DAISY). The Journal of Clinical Endocrinology & Metabolism, 98(11), E1845-E1851.
Huang-Doran, I., & Franks, S. (2016). Genetic rodent models of obesity-associated ovarian dysfunction and subfertility: insights into polycystic ovary syndrome. Frontiers in endocrinology, 7, 53.
Jahromi, B. N., Dabaghmanesh, M. H., Parsanezhad, M. E., & Fatehpoor, F. (2017). Association of leptin and insulin resistance in PCOS: A case-controlled study. International Journal of Reproductive BioMedicine, 15(7), 423.
Jalilian, N., Haghnazari, L., & Rasolinia, S. (2016). Leptin and body mass index in polycystic ovary syndrome. Indian journal of endocrinology and metabolism, 20(3), 324-328.
Lecke, S. B., Morsch, D. M., & Spritzer, P. M. (2013). Association between adipose tissue expression and serum levels of leptin and adiponectin in women with polycystic ovary syndrome. Genet Mol Res, 12(4), 4292-4296.
Mannerås-Holm, L., Leonhardt, H., Kullberg, J., Jennische, E., Odén, A., Holm, G., ... & Lönn, M. (2011). Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. The Journal of Clinical Endocrinology & Metabolism, 96(2), E304-E311.
Mohiti-Ardekani, J., & Taarof, N. (2010). Comparison of leptin blood levels and correlation of leptin with LH and FSH in PCOS patients and normal individuals. SSU_Journals, 17(5), 353-357.
Murri, M., Luque-Ramírez, M., Insenser, M., Ojeda-Ojeda, M., & Escobar-Morreale, H. F. (2013). Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Human reproduction update, 19(3), 268-288.
Narayanaswamy, N. L., Ramanathan, F., & Manjuladevi, M. T. (2023). Diagnostic utility of serum anti-Mullerian hormone levels in south Indian women with polycystic ovarian syndrome. Biomedicine, 43(4), 1215-1219.
Rizk, N. M., & Sharif, E. (2015). Leptin as well as free leptin receptor is associated with polycystic ovary syndrome in young women. International journal of endocrinology, 2015(1), 927805.
Rojas, J., Chávez, M., Olivar, L., Rojas, M., Morillo, J., Mejías, J., ... & Bermúdez, V. (2014). Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. International journal of reproductive medicine, 2014(1), 719050.
Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Human reproduction, 19(1), 41-47.
Seth, M. K., Gulati, S., Gulati, S., Kumar, A., Rawat, D., Kumari, A., ... & Gulati, A. (2021). Association of leptin with polycystic ovary syndrome: a systematic review and meta-analysis. The Journal of Obstetrics and Gynecology of India, 71(6), 567-576.
Veena Kirthika, S., Paul, J., Senthil Selvam, P., & Sathya Priya, V. (2019). Effect of progressive resisted exercises and aerobic exercises in the management of polycystic ovarian syndrome among young women-A pilot randomized controlled trial. INDIAN ASSOCIATION OF BIOMEDICAL SCIENTISTS (IABMS)[Volume 39 Number 4 (October-December) 2019; www. biomedicineonline. org], 39(4), 608-612.
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011). Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertility and sterility, 95(3), 1073-1079. https://doi.org/10.1016/j.fertnstert.2010.12.027
Yau, T. T., Ng, N. Y., Cheung, L. P., & Ma, R. C. (2017). Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences. Hong Kong Medical Journal, 23(6), 622.
Zieba, D. A., Amstalden, M., & Williams, G. L. (2005). Regulatory roles of leptin in reproduction and metabolism: a comparative review. Domestic animal endocrinology, 29(1), 166-185. https://doi.org/10.1016/j.domaniend.2005.02.019
Published
How to Cite
Issue
Section
Copyright (c) 2025 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
